The absence of spermatogenesis in radical orchiectomy specimen is associated with advanced-stage nonseminomatous testicular cancer

•Imparied spermatogenesis is common among men diagnosed with testicular cancer•Absence of spermatogenesis is a common finding in the cancerous testicle•Absence of spermatogenesis was found to be associated with advanced stage of NSGCT To assess if clinical, pathological, and spermatogenesis factors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2021-12, Vol.39 (12), p.838.e15-838.e20
Hauptverfasser: Halstuch, Daniel, Shtabholtz, Yariv, Neufeld, Shmuel, Yakimov, Maxim, Altman, Eran, Stein, Anat, Baniel, Jack, Shoshany, Ohad, Golan, Shay
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Imparied spermatogenesis is common among men diagnosed with testicular cancer•Absence of spermatogenesis is a common finding in the cancerous testicle•Absence of spermatogenesis was found to be associated with advanced stage of NSGCT To assess if clinical, pathological, and spermatogenesis factors are associated with clinical staging in patients with testicular germ cell tumors. We retrospectively reviewed the pathology reports and slides from 267 men who underwent radical orchiectomy for testicular cancer at our institution during 1998-2019. Histologic slides were reviewed and the presence of mature spermatozoa was documented. Clinical, laboratory and radiographic characteristics were recorded. Logistic regression analyses were used to identify factors associated with advanced disease stage at diagnosis. Of 267 male patients, 115 (43%) patients had testicular non-seminomatous germ cell tumors (NSGCT) and 152 (57%) seminomatous germ cell tumors (SGCT). Among NSGCT patients, those presenting with metastatic disease had a higher proportion of predominant (>50%) embryonal carcinoma (64% vs. 43%, respectively, P = 0.03), and lymphovascular invasion (45.8% vs. 26.6%, respectively, P = 0.03) than non-metastatic patients. Spermatogenesis was observed in 56/65 (86.2%) and 36/49 (73.5%) of non-metastatic and metastatic NSGCT patients, respectively (P = 0.09). On semen analysis, severe oligospermia (
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2021.08.004